GlassScriptPhysician profile
Eduardo C Sabates
NPI 1851385686
$8,037.81
in general payments reported to CMS, 2019-2025
39 companies · $870 in 2025
The $870 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554 · 2020: $797 · 2021: $1,112 · 2022: $687 · 2023: $1,869 · 2024: $2,148 · 2025: $870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,887.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,203.38 | 2021-2025 | Pulseselect, Symplicity G3, Arctic Front Advance |
| Abbott Laboratories | $1,352.49 | 2020-2025 | Gallant, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Janssen Pharmaceuticals, INC | $734.24 | 2019-2023 | Xarelto |
| Abiomed | $560.14 | 2020-2024 | Impella |
| Boston Scientific Corporation | $459.20 | 2022-2025 | Watchman Flx, Watchman, Watchman Access System |
| Philips North America LLC | $208.81 | 2024 | (Cm9) Amb Mon & Diag Und, (5091) Amb Mon & Diag Und |
| E.R. Squibb & Sons, L.L.C. | $185.63 | 2022-2025 | Camzyos, Eliquis |
| Inari Medical, INC. | $177.71 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $176.62 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $157.91 | 2022-2024 | Optimizer |
| Edwards Lifesciences Corporation | $154.00 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.75 | 2019-2024 | Jardiance |
| Novo Nordisk INC | $143.79 | 2023 | Ozempic |
| Siemens Medical Solutions USA, INC. | $113.18 | 2019 | |
| Heartflow, INC. | $105.00 | 2023-2025 | Ffrct |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $102.05 | 2023-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.43 | 2019-2024 | Lifevest |
| Amarin Pharma, INC. | $92.58 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $73.02 | 2019-2025 | |
| Biotronik INC. | $71.28 | 2019 | |
| Pfizer INC. | $71.22 | 2021-2024 | |
| Cordis US Corp. | $70.25 | 2023-2025 | Mynx Control, Rain Sheath |
| Astrazeneca Pharmaceuticals LP | $64.80 | 2020-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $64.48 | 2019 | |
| Atricure, INC. | $54.20 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Insulet Corporation | $50.86 | 2020 | |
| Medtronic Vascular, INC. | $45.25 | 2019 | |
| Agepha Pharma Fz LLC | $42.34 | 2024-2025 | Lodoco |
| Penumbra, INC. | $35.00 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $32.22 | 2021-2022 | |
| Bardy Diagnostics, INC. | $30.00 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $25.15 | 2025 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $24.81 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $19.62 | 2024 | |
| Cleerly, INC. | $18.52 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Ge Healthcare | $18.30 | 2021 | |
| Irhythm Technologies, INC. | $16.95 | 2023 | Zio Xt Patch |
| Gilead Sciences, INC. | $14.89 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Sabates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.